CochLear (OTCMKTS:CHEOY) Sets New 12-Month Low – Should You Sell?

CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOYGet Free Report) shares reached a new 52-week low during trading on Tuesday . The company traded as low as $66.48 and last traded at $67.13, with a volume of 873 shares trading hands. The stock had previously closed at $70.60.

Wall Street Analysts Forecast Growth

Separately, Royal Bank Of Canada raised shares of CochLear from a “hold” rating to a “moderate buy” rating in a research report on Monday, January 19th. Two analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy”.

View Our Latest Stock Analysis on CochLear

CochLear Stock Down 3.0%

The company has a fifty day simple moving average of $85.29 and a 200 day simple moving average of $90.56.

About CochLear

(Get Free Report)

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Further Reading

Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.